Owens & Minor

Owens & Minor, Inc. engages in the provision of healthcare solutions. It operates through the Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owens & Minor achieves record revenue, focuses on cost-saving initiatives

Owens & Minor's Q4 2022 performance reflects record revenue, strong segment growth, and strategic initiatives to drive profitability and operational efficiency.
While facing challenges in certain divisions, the company's focus on cost-saving programs and market competitiveness positions it well for future growth and success.
With a positive outlook for 2023, Owens & Minor aims to capitalize on opportunities for growth, cash flow improvement, and market expansion to drive shareholder value.

Owens & Minor reports solid Q1 results, raises 2023 outlook

Owens & Minor's Q1 performance reflects a mix of successes and challenges, with a strong focus on realignment and debt reduction. The company is optimistic about future growth prospects, particularly in the patient direct segment, and remains committed to enhancing operational efficiency and capital deployment.

Owens & Minor reports strong Q2 performance amidst PPE challenges

Owens & Minor's Q2 performance reflects positive momentum with growth in key segments and a focus on financial health through debt reduction.
Challenges in the PPE market and uncertainties in demand highlight the need for strategic planning and risk management strategies.
The company's strengths in revenue growth drivers and new business contracts position it well for future growth opportunities and financial success.

Owens & Minor (OMI) posts strong Q3 results, eyes growth opportunities

Owens & Minor (OMI) reported a solid Q3 performance with revenue growth, debt reduction, and operational efficiency driving financial resilience.
While facing challenges in market visibility and regulatory changes, the company remains well-positioned to capitalize on growth opportunities and enhance shareholder value.
Strategic focus on key segments and profitability improvement initiatives set a positive trajectory for future growth and value creation.
Investors can look forward to sustained performance and profitability as Owens & Minor navigates challenges and seizes growth opportunities in the evolving healthcare landscape.

Owens & Minor (OMI) reports robust Q4 earnings and outlines growth strategy for 2024

Owens & Minor (OMI) showcased strong financial performance in Q4 2023, with a positive outlook for 2024. Despite challenges in EBITDA calculations and deal delays, the company remains focused on strategic investments and operational optimization.

Owens & Minor (OMI) reports robust Q1 performance and growth outlook

Owens & Minor (OMI) delivered strong financial performance in Q1 2024, driven by revenue growth and margin expansion initiatives despite challenges in cash flow and debt reduction.
The company's strategic focus on operational efficiency, cost reduction, and long-term investments positions it well for future growth and market opportunities.
With a solid foundation in place and a clear growth strategy, Owens & Minor (OMI) is poised to navigate challenges and leverage opportunities for sustained success.

Owens & Minor reports revenue growth and strategic acquisitions in Q2

Owens & Minor's Q2 performance showed revenue growth and improved operating income, despite a GAAP net loss.
The acquisition of Rotech Healthcare strengthens the Patient Direct segment, driving revenue growth.
Challenges include managing costs, addressing tariffs' impact, and balancing segment optimization with expansion.
Opportunities exist in leveraging acquisitions, expanding product offerings, and enhancing operational efficiency.

Owens & Minor reports solid Q3 performance and eyes growth

Owens & Minor demonstrated resilience and strategic focus in Q3 2024, with strong financial results and debt reduction achievements.
While facing challenges such as supply chain issues and tariff impacts, the company remains optimistic about growth opportunities.
Investors can look forward to the Rotech acquisition and the company's commitment to operational excellence and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor to Present at the Barclays Global Healthcare Conference Tuesday, March 15, 2022

Owens & Minor to Present at the Barclays Global Healthcare Conference Tuesday, March 15, 2022

RICHMOND, Va.--(BUSINESS WIRE)--Owens and Minor to Present at the J.P. Morgan Global High Yield & Leveraged Finance Conference

Owens & Minor to Present at the J.P. Morgan High Yield & Leveraged Finance Conference Monday, February 28, 2022

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor Selects Kenny Gardner to Join Board of Directors

Owens & Minor Selects Kenny Gardner to Join Board of Directors

Owens & Minor Inc (NYSE: OMI) has reported adjusted EPS of $0.81 in Q4, lower than $1.14 a year ago but ahead of the consensus of $0.71. Revenue for the quarter increased 4.45% to $2.47 billion, better than the consensus estimate of $2.43 billion.

Why Owens & Minor's Shares Are Trading Higher Today

Owens & Minor, Inc. (OMI) CEO Ed Pesicka on Q4 2021 Results - Earnings Call Transcript

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor Reports Fourth Quarter and Full Year 2021 Financial Results

Owens & Minor Reports Fourth Quarter and Full Year 2021 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor to Present at the Citi 2022 Virtual Healthcare Conference on Thursday, February 24th

Owens & Minor to Present at the Citi 2022 Virtual Healthcare Conference Thursday, February 24, 2022

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor Will Report Fourth Quarter & Full Year Financial Results on Wednesday, February 23, 2022

Owens & Minor Will Report Fourth Quarter & Full Year Financial Results on Wednesday, February 23, 2022

RICHMOND, Va.--(BUSINESS WIRE)-- #Birthday--Owens & Minor Marks 140th Year of Serving Customers & Advancing Healthcare

Owens & Minor Celebrates 140 Years of Healthcare Service

NEW ORLEANS, Jan. 15, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

APRIA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apria, Inc. - APR

Owens & Minor (OMI) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

What Makes Owens & Minor (OMI) a Good Fit for "Trend Investing"

Apria Inc (NASDAQ: APR) spiked 25% after it announced that it had entered a definitive agreement with Owens & Minor (NYSE: OMI) whereby Owens would acquire its common stock shares for $37.50 per share representing a total equity value of roughly $1.45 billion.  The strategic rationale of the deal The deal is set to strengthen the […] The post Apria Inc up 25% after signing a definitive agreement with Owens & Minor appeared first on Invezz.

Apria Inc up 25% after signing a definitive agreement with Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) announced it is buying Apria, Inc. (Nasdaq: APR) for $1.45 billion. These are the details The post Why Owens & Minor (OMI) Is Buying Apria (APR) For $1.45 Billion appeared first on Pulse 2.0.

Why Owens & Minor (OMI) Is Buying Apria (APR) For $1.45 Billion

The healthcare logistics firm Owens & Minor announced Monday (Jan. 10) it will acquire the home health equipment provider Apria in a transaction worth $1.6 billion.  Owens & Minor President and CEO Edward A.

Healthcare Firm Owens & Minor Buys Apria for $1.6B

Healthcare technology company Owens & Minor Inc. OMI, +2.64% said Monday it has agreed to acquire Apria Inc. APR, -3.54% in a deal with an equity value of about $1.45 billion. Under the terms of the deal, the company will pay $37.50 per Apria share in cash, equal to a 26% premium over the stock's closing price on Jan. 7 and 24% over its 30-day volume weighted average price.

Owens & Minor to acquire Apria in deal with equity value of about $1.45 billion

RICHMOND, Va. & INDIANAPOLIS--(BUSINESS WIRE)--Owens & Minor, Inc. (“Owens & Minor”) (NYSE: OMI) and Apria, Inc. (“Apria”) (Nasdaq: APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. “I'm very excited about the acquisition of Apria, which will strengthen our total company value proposition. The com

Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

OMI, as a leading PPE manufacturer, has generated strong growth during the pandemic with higher earnings.

Owens & Minor: Pandemic Winner Has More Upside In 2022

Owens & Minor (OMI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About Owens & Minor (OMI) Rating Upgrade to Buy

RICHMOND, Va.--(BUSINESS WIRE)-- #CSR--Owens & Minor Foundation reports on first six months, looks to continued activity in support of healthcare, environment, and D&I efforts.

Owens & Minor Foundation Reports Achievements of First Six Months, Looks Ahead to 2022

RICHMOND, Va.--(BUSINESS WIRE)-- #CivicLeaders--Owens & Minor announces winners of Tenth Annual Earl G. Reubel Awards

Owens & Minor Announces Winners of 2021 Earl G. Reubel Awards

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE-OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, today announced that Andy Long, the Company's Executive Vice President & Chief Financial Officer, will present at the Bank of America Securities Leveraged Finance Conference on Tuesday, November 30, 2021 at 3:45 pm EST. A live webcast and replay of the session will be available on the Inves

Owens & Minor to Present at Bank of America Leveraged Finance Conference

RICHMOND, Va.--(BUSINESS WIRE)-- #Health--Owens & Minor launched SAFESKIN* Nitrile Gloves, a new consumer brand, that offers task-focused, high quality protection and comes in POP-N-GO packs.

New SAFESKIN* Nitrile Gloves in POP-N-GO* Packs Provide On-The-Go Protection

Axcella Health Inc

Casey's General Stores

Lazydays

Sunopta

Want to try an out-of-the-box approach? Tap five stocks, namely OMI, STKL, CASY, LAZY and AXLA, with increasing P/E ratios.

5 Winning Stocks Backed by the Overlooked Rising P/E Ratio

The stock price of Owens & Minor, a global healthcare logistics company, has seen a rise of 38% over the last month, while it is up a solid 20% over the last week. The recent rise can be attributed to the company's upbeat Q3 results.

Is A Fall Imminent In Owens & Minor Stock After A Large 38% Rise In A Month?

RICHMOND, Va.--(BUSINESS WIRE)-- #DI--Owens & Minor Board Members Aster Angagaw & Retired Lt. Gen. Gwendolyn Bingham Named 2021 Most Influential Black Corporate Directors by Savoy Magazine

News for Owens & Minor Stock (OMI)